{
  "title": "Circulating Endocannabinoids and Cognitive Function in Older AdultsAn introduction to the endogenous cannabinoid systemThe endocannabinoid system and its therapeutic exploitationThe endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disordersEndocannabinoid signalling and the deteriorating brainGoods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 YearsPotential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer\u2019s DiseaseCannabinoids and the expanded endocannabinoid system in neurological disordersThe endocannabinoid system and the brainMultiple functions of endocannabinoid signaling in the brainThe Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal StudiesTherapeutic effect of palmitoylethanolamide in cognitive decline: A systematic review and preliminary meta-analysis of preclinical and clinical evidenceModulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer\u2019s DiseaseThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injurySex differences and the endocannabinoid system in painSex difference in brain CB1 receptor availability in manApolipoprotein E4 disrupts the neuroprotective action of sortilin in neuronal lipid metabolism and endocannabinoid signalingRelationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet interventionEndocannabinoids in Alzheimer\u2019s disease and their impact on normative cognitive performance: a case-control and cohort studyElevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer\u2019s Disease Patients as a Potential Protective Mechanism against Neurodegenerative DeclineEpidemiological approaches to heart disease: the Framingham StudyThe framingham offspring study. Design and preliminary dataThe Alzheimer\u2019s Disease Centers\u2019 Uniform Data Set (UDS): the neuropsychologic test batteryDifferential Effects of Endocannabinoids on Amyloid-Beta Aggregation and ToxicityCirculating Endocannabinoids: From Whence Do They Come and Where are They Going?Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes\u2014a Short ReviewFatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic PotentialFree fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer\u2019s diseaseCirculating Omega-3 and Omega-6 Fatty Acids, Cognitive Decline, and Dementia in Older AdultsLinoleic acid-good or bad for the brain?Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory StudyCorrelation of the Serum Fatty Acids with Cognitive Function: An NHANES 2011-2014 and Multivariate Mendelian Randomization AnalysisThe dietary fatty acids \u03b1-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide productionAPOE and the Association of Fatty Acids with the Risk of Stroke, Coronary Heart Disease, and MortalityEffects of APOE4 on omega-3 brain metabolism across the lifespanImpact of \u03b1-Linolenic Acid, the Vegetable \u03c9-3 Fatty Acid, on Cardiovascular Disease and CognitionOmega-3 blood biomarkers relate to brain glucose uptake in individuals at risk of Alzheimer\u2019s disease dementiaConsumption of Oleic Acid on the Preservation of Cognitive Functions in Japanese Elderly IndividualsNeuroprotective effects of oleic acid in rodent models of cerebral ischaemiaThe Neuroinflammatory and Neurotoxic Potential of Palmitic Acid Is Mitigated by Oleic Acid in Microglial Cells and Microglial-Neuronal Co-culturesFish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive FunctionLipids and Alzheimer\u2019s DiseasePalmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer\u2019s DiseaseUltramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer\u2019s disease by exerting anti-inflammatory and neuroprotective effectsAnandamide and other -acylethanolamines: A class of signaling lipids with therapeutic opportunitiesMicroglia and Astrocytes in Alzheimer\u2019s Disease: Significance and Summary of Recent AdvancesPrimary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer\u2019s Disease biomarker discovery cohortN-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cellsThe cell cycle in Alzheimer disease: a unique target for neuropharmacologyThe association of circulating endocannabinoids with neuroimaging and blood biomarkers of neuro-injuryNon-dietary factors associated with n-3 long-chain PUFA levels in humans - a systematic literature reviewEffects of menopausal hormone therapy on erythrocyte n-3 and n-6 PUFA concentrations in the Women\u2019s Health Initiative randomized trialDietary fatty acids and risk of Alzheimer\u2019s disease and related dementias: Observations from the Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP)Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer\u2019s Dementia in the Oldest OldThe influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysisEffects of vitamins and polyunsaturated fatty acids on cognitive function in older adults with mild cognitive impairment: a meta-analysis of randomized controlled trialsInhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female ratsSex specific effects of the fatty acid amide hydrolase inhibitor URB597 on memory and brain \u03b22-adrenergic and D1-dopamine receptorsPotential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitorsEndocannabinoid system alterations in Alzheimer\u2019s disease: A systematic review of human studiesCannabinoidomics - An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolomeThe emerging role of the endocannabinoid system in cardiovascular diseaseDiets to promote healthy brain ageingRelationship Between Cognitive Performance, Physical Activity, and Socio-Demographic/Individual Characteristics Among Aging AmericansMediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammationExercise activates the endo-cannabinoid system",
  "pmcid": "12727136",
  "features": {
    "sample_size": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "randomization": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "randomized controlled trial"
      ],
      "examples": [
        {
          "match": "randomized controlled trial",
          "context": "mpairment: a meta-analysis of randomized controlled trialsInhibition of fatty-acid amid"
        }
      ]
    },
    "blinding": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "blinded"
      ],
      "examples": [
        {
          "match": "blinded",
          "context": "s (duplicated tubes that were blinded to the laboratory where the e"
        }
      ]
    },
    "allocation_concealment": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "interaction_subgroup": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "interaction term",
        "stratification"
      ],
      "examples": [
        {
          "match": "interaction term",
          "context": "e study outcomes by including interaction terms of each eCB with these varia"
        },
        {
          "match": "interaction term",
          "context": "he models. In cases where the interaction terms were statistically significa"
        },
        {
          "match": "stratification",
          "context": "DR (p-value<0.05) By sex: sex stratification is shown only for models with"
        }
      ]
    },
    "variable_definitions": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "analysis_principles": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "itt_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "software": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "sas version 9.4"
      ],
      "examples": [
        {
          "match": "SAS version 9.4",
          "context": "analyses were conducted using SAS version 9.4. CAPTION: Sample characterist"
        }
      ]
    },
    "error_measures": {
      "present": true,
      "count": 4,
      "unique_matches": [
        "sd",
        "standard deviation",
        "standard error"
      ],
      "examples": [
        {
          "match": "standard deviation",
          "context": ". Outliers were defined as \u00b14 standard deviation from the mean and excluded (<"
        },
        {
          "match": "standard deviation",
          "context": "les were reported as mean and standard deviation or median (q1, q3) in case of"
        },
        {
          "match": "Standard error",
          "context": "gnitive function. FOOTER: SE, Standard error; Bold values indicate statist"
        }
      ]
    },
    "multiplicity_correction": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "multiple comparisons",
        "false discovery rate"
      ],
      "examples": [
        {
          "match": "False Discovery Rate",
          "context": "ant results. In addition, the False Discovery Rate (FDR) method was used to corr"
        },
        {
          "match": "multiple comparisons",
          "context": "ethod was used to correct for multiple comparisons in the total sample. Next, we"
        },
        {
          "match": "multiple comparisons",
          "context": ".05) after FDR correction for multiple comparisons Cognitive function: Verbal me"
        }
      ]
    },
    "normality_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "p_values": {
      "present": true,
      "count": 8,
      "unique_matches": [
        "p<0.05",
        "p-value"
      ],
      "examples": [
        {
          "match": "p<0.05",
          "context": "ate statistical significance (p<0.05) after FDR correction for mul"
        },
        {
          "match": "p-value",
          "context": "xamination. For each model, a p-value of 0.05 was used to indicate"
        },
        {
          "match": "p-value",
          "context": "lly significant (defined as a p-value < 0.1 due to low power of the"
        }
      ]
    },
    "confidence_intervals": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "comparative_stats": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "non_parametric": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "advanced_modeling": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "assumption_checks": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "survival_analysis": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "regression_and_models": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "reporting_guidelines": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "data_types": {
      "present": true,
      "count": 5,
      "unique_matches": [
        "categorical",
        "continuous",
        "binary"
      ],
      "examples": [
        {
          "match": "Categorical",
          "context": "ase of a skewed distribution. Categorical variables were presented as f"
        },
        {
          "match": "continuous",
          "context": "ty-four eCBs were analyzed as continuous variables with normal distrib"
        },
        {
          "match": "Continuous",
          "context": "at least one ApoE \u025b4 allele. Continuous variables were reported as me"
        }
      ]
    },
    "dependency": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "longitudinal"
      ],
      "examples": [
        {
          "match": "longitudinal",
          "context": "in 1948 and is a single-site, longitudinal community-based cohort study"
        }
      ]
    },
    "clustering": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "missing_data": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "effect_size": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "post_hoc": {
      "present": true,
      "count": 2,
      "unique_matches": [
        "multiple comparisons"
      ],
      "examples": [
        {
          "match": "multiple comparisons",
          "context": "ethod was used to correct for multiple comparisons in the total sample. Next, we"
        },
        {
          "match": "multiple comparisons",
          "context": ".05) after FDR correction for multiple comparisons Cognitive function: Verbal me"
        }
      ]
    },
    "baseline_reporting": {
      "present": true,
      "count": 1,
      "unique_matches": [
        "table 1"
      ],
      "examples": [
        {
          "match": "Table 1",
          "context": "tectable value. Supplementary Table 1 shows the full list of eCB co"
        }
      ]
    },
    "advanced_modeling_extra": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "excluded"
      ],
      "examples": [
        {
          "match": "excluded",
          "context": "p. Thirteen participants were excluded due to a diagnosis of dementi"
        },
        {
          "match": "excluded",
          "context": "imit. Of the 58 eCBs, 14 were excluded because precise values for >9"
        },
        {
          "match": "excluded",
          "context": "d deviation from the mean and excluded (<2% of values) because they"
        }
      ]
    },
    "systematic_review_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "diagnostic_metrics": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "model_details": {
      "present": false,
      "count": 0,
      "unique_matches": [],
      "examples": []
    },
    "domain_indicators": {
      "present": true,
      "count": 3,
      "unique_matches": [
        "in vitro",
        "mouse model",
        "transgenic"
      ],
      "examples": [
        {
          "match": "mouse model",
          "context": "rments in a triple transgenic mouse model of Alzheimer\u2019s disease by exe"
        },
        {
          "match": "In vitro",
          "context": "au and amyloid beta peptides. In vitro evidence for a common effecto"
        },
        {
          "match": "transgenic",
          "context": "emory impairments in a triple transgenic mouse model of Alzheimer\u2019s di"
        }
      ]
    }
  },
  "feedback": {
    "overall_score": 2.5,
    "rigor_rating": "Low",
    "critical_gaps": [
      {
        "message": "P-values reported without effect sizes (e.g. Odds Ratio).",
        "evidence": "...ate statistical significance (p<0.05) after FDR correction for mul..."
      },
      {
        "message": "Paired data mentioned but no paired statistical tests found.",
        "evidence": "...in 1948 and is a single-site, longitudinal community-based cohort study..."
      },
      {
        "message": "Categorical data mentioned, but no appropriate categorical tests found.",
        "evidence": "...ase of a skewed distribution. Categorical variables were presented as f..."
      },
      {
        "message": "Longitudinal/clustered data detected without hierarchical modeling.",
        "evidence": "...in 1948 and is a single-site, longitudinal community-based cohort study..."
      },
      {
        "message": "Data exclusion criteria should be explicitly detailed.",
        "evidence": "...p. Thirteen participants were excluded due to a diagnosis of dementi..."
      }
    ],
    "strengths": [
      {
        "message": "Analysis context identifies basic science or bioinformatics (Softened clinical trial requirements).",
        "evidence": "Detected term: 'in vitro'"
      },
      {
        "message": "Explicitly addressed multiplicity correction for multiple comparisons.",
        "evidence": "...ant results. In addition, the False Discovery Rate (FDR) method was used to corr..."
      },
      {
        "message": "Detailed software versions provided.",
        "evidence": "...analyses were conducted using SAS version 9.4. CAPTION: Sample characterist..."
      },
      {
        "message": "Performed pre-planned or correctly adjusted post hoc comparisons.",
        "evidence": "...ethod was used to correct for multiple comparisons in the total sample. Next, we..."
      }
    ],
    "actionable_recommendations": [
      {
        "item": "Effect Sizes",
        "issue": "Significance reported without magnitude.",
        "recommendation": "Report Effect Sizes with CIs.",
        "source_text": "Detected 'p<0.05' but did not find Effect Size keywords (e.g., OR, HR, Cohen's d)."
      },
      {
        "item": "Statistical Architecture",
        "issue": "Clustered/repeated data requires hierarchical models.",
        "recommendation": "Use LMM, GLMM, or GEE.",
        "source_text": "Found 'longitudinal' but no mixed-effects models."
      }
    ],
    "deterministic_audit": true
  }
}